1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Endometrioid carcinoma of the ovary: a retrospective study
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1988.tb06795.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 95, Issue 11, pages 1165–1169, November 1988
Additional Information
How to Cite
TIDY, J. and MASON, W. P. (1988), Endometrioid carcinoma of the ovary: a retrospective study. BJOG: An International Journal of Obstetrics & Gynaecology, 95: 1165–1169. doi: 10.1111/j.1471-0528.1988.tb06795.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 13 September 1987, Accepted 16 March 1988
- Abstract
- References
- Cited By
Summary. Thirty-nine women with endometrioid carcinoma of the ovary were studied for factors relating to their presentation, treatment and survival. Nine of the women (23%) had a concomitant adenocarcinoma of the endometrium at the time of presentation. There were no significant differences in age at presentation or menopausal status between the two groups. The actuarial 5-year survival for women with endometrioid carcinoma of the ovary alone was 43%, 95% confidence interval (CI) 24% to 62% (stage 180%, CI45% to 100%, stage II62%, CI27% to 97%, and stage III 21%, CI 0% to 42%). The 5-year survival for women with concomitant endometrial tumours was 62.5% (CI 28.5% to 96.5%). The difference in the overall survival rate between the two groups was not significant.